PA
MEI icon

PharVision Advisers’s Methode Electronics MEI Stock Holding History

PharVision Advisers’s Portfolio MEI Stock Details MEI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,144
Closed -$120K – 419
2024
Q4 		$120K Buy
+10,144
New +$110K 0.1% 365

Other funds holding MEI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's MEI Position: Q1 2025 in Review

PharVision Advisers sold out of Methode Electronics (MEI) in Q1 2025, closing a stake of 10,144 shares — an estimated $120K sold.

PharVision Advisers first reported a position in MEI in Q4 2024 and held it in 1 quarter. The position peaked at $120K in Q4 2024. 155 funds tracked by Wall St. Rank hold MEI as of Q1 2025.

  • PharVision Advisers reported no remaining Methode Electronics position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 10,144 Methode Electronics shares in Q1 2025, an estimated $120K.
  • PharVision Advisers first reported a position in Methode Electronics in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Methode Electronics position peaked at $120K in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Methode Electronics as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.